Zolpidem and Haemangioma of skin - a phase IV clinical study of FDA data


Haemangioma of skin is found among people who take Zolpidem, especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Zolpidem and have Haemangioma of skin. It is created by eHealthMe based on reports of 80,705 people who have side effects when taking Zolpidem from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

80,705 people reported to have side effects when taking Zolpidem.
Among them, 13 people (0.02%) have Haemangioma of skin.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 82,981 Zolpidem users for its effectiveness, alternative drugs and more.

What is Haemangioma of skin?

Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs) is found to be associated with 536 drugs and 280 conditions by eHealthMe.

Number of Zolpidem and Haemangioma of skin reports submitted per year:

Could Zolpidem cause Haemangioma of skin?

Time on Zolpidem when people have Haemangioma of skin *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haemangioma of skin when taking Zolpidem *:

  • female: 84.62 %
  • male: 15.38 %

Age of people who have Haemangioma of skin when taking Zolpidem *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 38.46 %
  • 30-39: 38.46 %
  • 40-49: 7.69 %
  • 50-59: 0.0 %
  • 60+: 15.38 %

Common drugs people take besides Zolpidem *:

  1. Ambien: 7 people, 53.85%
  2. Lorazepam: 6 people, 46.15%
  3. Triphasil-21: 5 people, 38.46%
  4. Floxin Otic: 5 people, 38.46%
  5. Desowen: 5 people, 38.46%
  6. Cipro: 5 people, 38.46%
  7. Naloxone: 5 people, 38.46%
  8. Cefotan: 5 people, 38.46%
  9. Morphine: 5 people, 38.46%
  10. Elidel: 5 people, 38.46%

Common side effects people have besides Haemangioma of skin *:

  1. Sinusitis (inflammation of sinus): 12 people, 92.31%
  2. Dizziness: 11 people, 84.62%
  3. Fatigue (feeling of tiredness): 10 people, 76.92%
  4. Weakness: 7 people, 53.85%
  5. Bone Pain: 6 people, 46.15%
  6. Neuropathy Peripheral (surface nerve damage): 6 people, 46.15%
  7. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 6 people, 46.15%
  8. Headache (pain in head): 6 people, 46.15%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 46.15%
  10. Abdominal Pain: 6 people, 46.15%

Common conditions people have *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 38.46%
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 38.46%
  3. Pain: 2 people, 15.38%
  4. Upper Respiratory Tract Infection: 1 person, 7.69%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 7.69%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
  7. Muscle Spasms (muscle contraction): 1 person, 7.69%
  8. Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
  9. Ill-Defined Disorder: 1 person, 7.69%
  10. Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem and have Haemangioma of skin?

Check whether Haemangioma of skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Haemangioma of skin and when was it recovered:

Expand to all the drugs that have ingredients of zolpidem tartrate:

Alternative drugs to, pros and cons of Zolpidem:

Common Zolpidem side effects:

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Haemangioma of skin treatments and more:

COVID vaccines that are related to Haemangioma of skin:

Common drugs associated with Haemangioma of skin:

All the drugs that are associated with Haemangioma of skin:

Common conditions associated with Haemangioma of skin:

All the conditions that are associated with Haemangioma of skin:

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Zolpidem) and Zolpidem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: